André Lieber

Scientific Co-Founder at HDT Bio
Seattle, Washington, United States

André Lieber is Academic Cofounder at HDT Bio and a contract Scientific Co-founder at Ensoma. He is also Professor at the University of Washington.

Seattle Startup HDT Bio Secures $1.8M U.S. Army Grant to Develop Broad-Spectrum Antiviral Nasal Spray by 2025

Seattle startup HDT Bio received a nearly $1.8 million U.S. Army grant to develop a nasal spray using proprietary RNA technology that targets a broad range of respiratory viruses, with clinical trials expected to begin in 2025. The spray aims to prevent virus replication and transmission and could be used by both military personnel and civilians.

Organizations

  • HDT Bio logo
    HDT Bio Scientific Co-Founder 2020–present · current
  • Ensoma Scientific Co-founder 2019–present · current
  • University of Washington logo
    University of Washington Professor 1994–present · current

Online